<SEC-DOCUMENT>0001104659-20-033141.txt : 20200313
<SEC-HEADER>0001104659-20-033141.hdr.sgml : 20200313
<ACCEPTANCE-DATETIME>20200313162141
ACCESSION NUMBER:		0001104659-20-033141
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200313
DATE AS OF CHANGE:		20200313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Clarus Corp
		CENTRAL INDEX KEY:			0000913277
		STANDARD INDUSTRIAL CLASSIFICATION:	 [3949]
		IRS NUMBER:				581972600
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-218752
		FILM NUMBER:		20712986

	BUSINESS ADDRESS:	
		STREET 1:		2084 EAST 3900 SOUTH
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84124
		BUSINESS PHONE:		801-278-5552

	MAIL ADDRESS:	
		STREET 1:		2084 EAST 3900 SOUTH
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84124

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Black Diamond, Inc.
		DATE OF NAME CHANGE:	20110121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLARUS CORP
		DATE OF NAME CHANGE:	19980911

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SQL FINANCIALS INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19980911
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2012513d1_424b3.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule&nbsp;424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration File No.: 333-218752</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;<IMG SRC="tm2012513d1_424b3img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLARUS CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>7,500,000&nbsp;Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates
to an aggregate of 7,500,000&nbsp;shares of common stock, par value $0.0001 per share, of Clarus Corporation, a Delaware corporation,
(&ldquo;Clarus&rdquo; or the &ldquo;Company&rdquo;), which may be issued from time to time by the Company in connection with acquisitions
by the Company of assets, businesses, or securities. We expect that the terms of acquisitions involving the issuance of any such
shares will be determined by direct negotiations with the owners or controlling persons of the assets, businesses or securities
to be acquired, and that the shares of common stock issued will be valued at prices reasonably related to the market price of the
common stock either at the time an agreement is entered into concerning the terms of the acquisition or at or about the time the
shares are delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not expect to
receive any cash proceeds when we issue shares of common stock offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock trades
on the Nasdaq Global Select Market (&ldquo;NASDAQ&rdquo;) under the symbol &ldquo;CLAR.&rdquo; On November&nbsp;15, 2017, the last
reported sales price of our common stock on NASDAQ was $7.30 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our
securities involves risks. Please refer to the &ldquo;Risk Factors&rdquo; section contained in any applicable prospectus supplement
and in the documents we incorporate by reference for a description of the risks you should consider when evaluating this investment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is December&nbsp;22,
2017 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Page</U></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#forward">FORWARD-LOOKING STATEMENTS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#forward">iii</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#pros">PROSPECTUS SUMMARY</A></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><A HREF="#pros">1</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#company">THE COMPANY</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#company">2</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#risk">RISK FACTORS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#risk">3</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#use">USE OF PROCEEDS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#use">3</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#des">DESCRIPTION OF COMMON STOCK</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#des">3</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#anti">ANTI-TAKEOVER EFFECTS OF CERTAIN PROVISIONS OF
    DELAWARE LAW AND OUR CERTIFICATE OF INCORPORATION AND BYLAWS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#anti">6</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#planof">PLAN OF DISTRIBUTION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#planof">7</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#selling">SELLING STOCKHOLDERS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#selling">8</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#where">WHERE YOU CAN FIND MORE INFORMATION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#where">9</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#incorp">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#incorp">9</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#experts">EXPERTS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#experts">10</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#legal">LEGAL MATTERS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#legal">10</A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>_______________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is
part of an &ldquo;acquisition shelf&rdquo; registration statement on Form&nbsp;S-4 that we filed with the Securities and Exchange
Commission, or the Commission, under the Securities Act of 1933, as amended, or the Securities Act, using an &ldquo;acquisition
shelf&rdquo; registration process. This prospectus relates to an aggregate of 7,500,000 shares of common stock, par value $0.0001
per share, of Clarus Corporation, a Delaware corporation which may be issued from time to time by the Company in connection with
acquisitions by the Company of assets, businesses, or securities. We expect that the terms of acquisitions involving the issuance
of any such shares will be determined by direct negotiations with the owners or controlling persons of the assets, businesses or
securities to be acquired, and that the shares of common stock issued will be valued at prices reasonably related to the market
price of the common stock either at the time an agreement is entered into concerning the terms of the acquisition or at or about
the time the shares are delivered. A prospectus supplement or post-effective amendment to this registration statement will contain
more specific information about an acquisition target or any of the terms of a definitive acquisition agreement. Any statement
that we make in this prospectus will be modified or superseded by any inconsistent statement made by us in a prospectus supplement
or post-effective amendment. Before deciding to receive any of our securities as part of an acquisition transaction, you should
read both this prospectus and any accompanying post-effective amendment together with the additional information described under
the headings &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Documents by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should rely only
on the information contained in this prospectus, any applicable prospectus supplement or any post-effective amendment and those
documents incorporated by reference in this prospectus or any post-effective amendment. We have not authorized anyone to provide
you with information different from that contained in this prospectus, any applicable prospectus supplement or any post-effective
amendment. If anyone provides you with different or additional information you should not rely on it. This prospectus may only
be used where it is legal to sell these securities. This prospectus is not an offer to sell, or a solicitation of an offer to buy,
in any state where the offer or sale is prohibited. The information in this prospectus, any applicable prospectus supplement any
post-effective amendment or any document incorporated herein or therein by reference is accurate as of the date contained on the
cover of such documents. Neither the delivery of this prospectus, any applicable prospectus supplement or any post-effective amendment,
nor any sale made under this prospectus or any post-effective amendment will, under any circumstances, imply that the information
in this prospectus, any applicable prospectus supplement or any post-effective amendment is correct as of any date after the date
of this prospectus or any such post-effective amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">References in this
prospectus to the &ldquo;Company,&rdquo; &ldquo;Clarus,&rdquo; &ldquo;we,&rdquo; &ldquo;our,&rdquo; and &ldquo;us,&rdquo; refer
to Clarus Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="forward"></A><B>FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain statements
included in this prospectus, any applicable prospectus supplement, any accompanying post-effective amendment and the documents
incorporated by reference herein and therein are &ldquo;forward-looking statements&rdquo; within the meaning of the federal securities
laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company
and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that
actual results could differ materially from those expressed or implied in the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Potential risks and
uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from
those expressed or implied by forward-looking statements in this prospectus, an applicable prospectus supplement, any accompanying
post-effective amendment and the documents incorporated herein and therein include, but are not limited to, the overall level of
consumer spending on our products; general economic conditions and other factors affecting consumer confidence; disruption and
volatility in the global capital and credit markets; the financial strength of the Company&rsquo;s customers; the Company&rsquo;s
ability to implement its growth strategy, including its ability to organically grow each of its historical product lines; the ability
of the Company to identify potential acquisition or investment opportunities as part of its redeployment and diversification strategy;
the Company&rsquo;s ability to successfully redeploy its capital into diversifying assets or that any such redeployment will result
in the Company&rsquo;s future profitability; the Company&rsquo;s ability to successfully integrate Sierra Bullets L.L.C.; the Company&rsquo;s
exposure to product liability or product warranty claims and other loss contingencies; stability of the Company&rsquo;s manufacturing
facilities and foreign suppliers; the Company&rsquo;s ability to protect trademarks, patents and other intellectual property rights;
fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations;
our ability to utilize our net operating loss carryforwards; and legal, regulatory, political and economic risks in international
markets. More information on potential factors that could affect the Company&rsquo;s financial results is included from time to
time in the Company&rsquo;s public reports filed with the Securities and Exchange Commission, including the Company&rsquo;s Annual
Report on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q and Current Reports on Form&nbsp;8-K. All forward-looking statements
included in this prospectus are based upon information available to the Company as of the date of this prospectus, and speak only
as the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the
date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should also read
carefully the factors described or referred to in the &ldquo;Risk Factors&rdquo; section of this prospectus, any applicable prospectus
supplement, any accompanying post-effective amendment and the documents incorporated by reference herein and therein, to better
understand the risks and uncertainties inherent in our business and underlying any forward-looking statements. Any forward-looking
statements that we make in this prospectus, any applicable prospectus supplement any accompanying post-effective amendment and
the documents incorporated by reference herein as well as other written or oral statements by us or our authorized officers on
our behalf, speak only as of the date of such statement, and we undertake no obligation to update such statements. Comparisons
of results for current and any prior periods are not intended to express any future trends or indications of future performance,
unless expressed as such, and should only be viewed as historical data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This document serves
as a prospectus of Clarus to register 7,500,000&nbsp;shares of our common stock, par value $0.0001&nbsp;per share, which we plan
to use in acquisition transactions from time to time in connection with the acquisition of assets, stock or businesses, whether
by purchase, merger or any other form of business combination. It is expected that the terms of these acquisitions will be determined
by direct negotiations with the owners or controlling persons of the assets, businesses or securities to be acquired, and that
the shares of common stock issued will be valued at prices reasonably related to the market price of our common stock either at
the time an agreement is entered into concerning the terms of the acquisition or at or about the time the shares are delivered.
In addition to shares of our common stock, consideration for these acquisitions may consist of any consideration permitted by applicable
law, including, without limitation, the payment of cash, the issuance of a note or other form of indebtedness, the assumption of
liabilities or any combination of these items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock we
issue pursuant to this prospectus and applicable prospectus supplement or post-effective amendment in these transactions may be
reoffered pursuant to this prospectus by the stockholders thereof from time to time in transactions on the NASDAQ (or any other
exchange on which our common stock may be listed or traded from time to time), in negotiated transactions, in block trades, through
the writing of options on securities, or any combination of these methods of sale, at fixed prices that may be changed, at market
prices prevailing at the time of sale, at prices relating to the prevailing prices or at negotiated prices. These selling stockholders
may sell their shares of common stock to or through broker-dealers, and the broker-dealers may receive compensation in the form
of discounts, concessions or commissions from the selling stockholders or the purchasers of shares for whom the broker-dealer may
act as agent or to whom they may sell as principal or both.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may
issue our common stock pursuant to this prospectus and applicable prospectus supplement amendment or post-effective amendment to
acquire the assets, stock or business of debtors in cases under the United States Bankruptcy Code, which may constitute all or
a portion of the debtor&rsquo;s assets, stock or business. The common stock we issue in these transactions may be sold by the debtor
or its stockholders for cash from time to time in market transactions or it may be transferred by the debtor in satisfaction of
claims by creditors under a plan of reorganization approved by the applicable U.S.&nbsp;Bankruptcy Court or otherwise transferred
in accordance with the Bankruptcy Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will bear all expenses
in connection with the registration of the common stock being resold by selling stockholders, other than selling discounts and
commissions and fees and expenses of the selling stockholders. The terms for the issuance of common stock may include provisions
for the indemnification of the selling stockholders for specified civil liabilities, including liabilities under the Securities
Act of 1933, as amended, or the Securities Act. The selling stockholders and any brokers, dealers or agents that participate in
the distribution of the common stock may be deemed to be underwriters, and any profit on the sale of stock by them and any discounts,
concessions or commissions received by any of these underwriters, brokers, dealers or agents may constitute underwriting discounts
and commissions under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="company"></A><B>THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Clarus is a holding
company which seeks opportunities to acquire and grow businesses that can generate attractive shareholder returns. Presently, through
its Outdoor Group, Clarus&rsquo; primary business is as a leading developer, manufacturer and distributor of outdoor equipment
and lifestyle products focused on the climb, ski, mountain, and technical categories. The Company&rsquo;s products are principally
sold under the Black Diamond&reg;, Sierra&reg; and PIEPS&reg; brand names through specialty and online retailers, distributors
and original equipment manufacturers throughout the U.S. and internationally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Through our Black Diamond&reg;
and PIEPS&reg; brands, we offer a broad range of products including: high performance apparel (such as jackets, shells, pants and
bibs); rock-climbing equipment (such as carabiners, protection devices, harnesses, belay devices, helmets, and ice-climbing gear);
technical backpacks and high-end day packs; tents; trekking poles; headlamps and lanterns; and gloves and mittens. We also offer
advanced skis, ski poles, ski skins, and snow safety products, including avalanche airbag systems, avalanche transceivers, shovels,
and probes. Sierra manufactures a wide range of high performance bullets for both rifles and pistols. Sierra bullets are used for
precision target shooting, hunting and military and law enforcement purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&nbsp;23, 2014,
the Company completed the sale of certain assets to Samsonite LLC comprising Gregory Mountain Products&rsquo; business. On March&nbsp;16,
2015, the Company announced that it was exploring a full range of strategic alternatives, including a sale of the entire Company
and the potential sales of the Company&rsquo;s Black Diamond Equipment (including PIEPS) and POC brands in two separate transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October&nbsp;7,
2015, the Company sold its equity interests in POC, resulting in the conclusion of the Company&rsquo;s review of strategic alternatives.
On November&nbsp;9, 2015, the Company announced that it was seeking to redeploy its significant cash balances to invest in high
quality, durable, cash flow-producing assets in order to diversify our business and potentially monetize our substantial net operating
losses as part of our asset redeployment and diversification strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&nbsp;14,
2017, the Company changed its name from Black Diamond,&nbsp;Inc. to Clarus Corporation and its stock ticker symbol from &ldquo;BDE&rdquo;
to &ldquo;CLAR&rdquo; on the NASDAQ stock exchange. On August&nbsp;21, 2017, the Company acquired Sierra Bullets, L.L.C. (&ldquo;Sierra&rdquo;),
a manufacturer of a wide range of bullets for both rifles and pistols.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Clarus, as a holding
company, is seeking opportunities to acquire and grow businesses that can generate attractive shareholder returns. The Company
has substantial net operating tax loss carryforwards which it is seeking to redeploy to maximize shareholder value in a diverse
array of businesses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are incorporated in Delaware, the address
of our executive corporate headquarters is located at 2084 East 3900 South, Salt Lake City, Utah 84124, and our telephone number
is (801) 278-5552.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="risk"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves risk. Please carefully consider the risk factors described in our periodic and current reports filed with the Commission,
which are incorporated by reference in this prospectus, as well as any risks that may be set forth in the prospectus supplement
relating to a specific security. Before making an investment decision, you should carefully consider these risks as well as other
information we include or incorporate by reference in this prospectus or include in any applicable prospectus supplement. These
risks could materially affect our business, results of operations or financial condition and cause the value of our securities
to decline. You could lose all or part of your investment. Additional risks and uncertainties not presently known to us or that
we deem currently immaterial may also impair our business operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="use"></A><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will receive no proceeds from the offering
of the shares other than the value of the assets, businesses, or securities acquired by us in acquisitions for which shares are
offered under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="des"></A><B>DESCRIPTION OF COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
of our common stock does not purport to be complete and is subject in all respects to applicable Delaware law and qualified by
reference to the provisions of our Amended and Restated Certificate of Incorporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;),
Amended and Restated Bylaws, as amended (the &ldquo;Bylaws&rdquo;), and Rights Agreement. Copies of our Certificate of Incorporation,
Bylaws, and Rights Agreement are incorporated by reference and will be sent to stockholders upon request. See &ldquo;Where Can
You Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Authorized Common Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have authorized 100,000,000 shares of our common stock, par value $0.0001 per share. As of November&nbsp;1, 2017 there were </FONT>30,041,265
shares of our common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Voting Rights, Dividend Rights, Liquidation
Rights and Other Rights</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of common stock
are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting
rights. Accordingly, as the Company has not implemented a staggered board of directors or granted stockholders cumulative voting
rights, holders of a majority of the shares of common stock that are entitled to vote in any election of directors will have the
ability to elect all of the directors standing for election. Holders of common stock are entitled to receive ratably such dividends,
if any, as may be declared by the board of directors of the Company (the &ldquo;Board&rdquo;) out of funds legally available therefor,
subject to any preferential dividend rights of outstanding preferred stock of the Company. Upon the liquidation, dissolution or
winding up of the Company, the holders of common stock are entitled to receive ratably the net assets of the Company available
after the payment of all debts and other liabilities and subject to the prior rights of any outstanding preferred stock of the
Company. Holders of common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and
privileges of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of
any series of preferred stock which the Company may designate and issue in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Acquisition Restrictions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To help ensure the
preservation of its net operating loss carryforwards (&ldquo;NOLs&rdquo;), the Company&rsquo;s Certificate of Incorporation generally
restricts any person from attempting to purchase or acquire (any such purchase or acquisition being an &ldquo;Acquisition&rdquo;),
any direct or indirect interest in Clarus&rsquo; capital stock (or options, warrants or other rights to acquire Clarus&rsquo; capital
stock, or securities convertible or exchangeable into Clarus&rsquo; capital stock), if such Acquisition would affect the percentage
of Clarus&rsquo; capital stock owned by a 5% stockholder (the &ldquo;Acquisition Restrictions&rdquo; and any person attempting
such an Acquisition, being referred to as a &ldquo;Restricted Holder&rdquo;). For purposes of determining the existence and identity
of, and the amount of capital stock owned by, any 5% stockholder or Restricted Holders, Clarus is entitled to rely conclusively
on (a)&nbsp;the existence and absence of filings of Schedules 13D and 13G (or any similar schedules) as of any date and (b)&nbsp;its
actual knowledge of the ownership of its capital stock. The Company&rsquo;s Certificate of Incorporation further provides that
a Restricted Holder will be required, prior to the date of any proposed Acquisition, to request in writing (a &ldquo;Request&rdquo;)
that the Board review the proposed Acquisition and authorize or not authorize such proposed Acquisition. If a Restricted Holder
seeks to effect an Acquisition, then at the next regularly scheduled meeting of the Board (which are generally held once during
each calendar quarter) following the tenth business day after receipt by the Secretary of the Company of a Request, the Board will
be required to determine whether to authorize the proposed Acquisition described in the Request. Any determination made by the
Board as whether to authorize a proposed Acquisition will be made in the sole discretion and judgment of the Board. The Board shall
promptly inform a Restricted Holder making the Request of such determination. Additionally, any Restricted Holder who makes such
a Request shall reimburse Clarus, on demand, for all reasonable costs and expenses incurred by Clarus with respect to any proposed
Acquisition, which may be material in relation to the Acquisition and will include the fees and expenses of any attorneys, accountants
or other advisors retained by Clarus in connection with such determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s
Certificate of Incorporation provides that any person who knowingly violates the Acquisition Restrictions or any persons in the
same control group with such person shall be jointly and severally liable to Clarus for, and shall indemnify and hold Clarus harmless
against, any and all damages suffered as a result of such violation, including but not limited to damages resulting from a reduction
in or elimination of the ability of Clarus to use its NOLs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All certificates representing
newly-issued shares of the Company&rsquo;s capital stock or shares voted in favor of the Acquisition Restrictions and subsequently
submitted for transfer, must bear the following legend:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5in 0pt 1in; text-align: justify">&ldquo;The Amended and Restated
Certificate of Incorporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;) of the Corporation contains restrictions
prohibiting the purchase or acquisition (collectively, the &ldquo;Acquisition&rdquo;) of any capital stock without the authorization
of the Board of Directors of the Corporation (the &ldquo;Board of Directors&rdquo;), if such Acquisition affects the percentage
of capital stock that is treated as owned by a five percent shareholder (within the meaning of Section&nbsp;382 of the Internal
Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), and the Treasury Regulations promulgated thereunder), and such Acquisition
would, in the sole discretion and judgment of the Board of Directors, jeopardize the Corporation&rsquo;s preservation of its U.S.
federal income tax attributes pursuant to Section&nbsp;382 of the Code and is not otherwise in the best interests of the Corporation
and its stockholders. The Corporation will furnish without charge to the holder of record of this certificate a copy of the Certificate
of Incorporation, containing the above-referenced restrictions on acquisitions of stock, upon written request to the Corporation
at its principal place of business.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has the discretion
to approve an Acquisition of stock that would otherwise violate the Acquisition Restrictions in circumstances where it determines
that such Acquisition is in the best interests of the Company and its stockholders. In determining whether or not to permit an
Acquisition which may result in violation of the Acquisition Restrictions, the Board may consider factors it deems relevant including
the likelihood that the Acquisition would result in an ownership change to occur that would limit the Company&rsquo;s use of its
NOLs. In addition, the Board is authorized to eliminate the Acquisition Restrictions, modify the applicable allowable percentage
ownership interest or modify any of the terms and conditions of the Acquisition Restrictions provided that the Board concludes
in writing that such change is reasonably necessary or advisable to preserve the Company&rsquo;s NOLs or that the continuation
of the affected terms and conditions of the Acquisition Restrictions is no longer reasonably necessary for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Acquisition Restrictions
may have anti-takeover effects because they will restrict the ability of a person or entity or group thereof from accumulating
an aggregate of 5% or more of the Company&rsquo;s capital stock and the ability of persons, entities or groups now owning 5% or
more of the Company&rsquo;s capital stock from acquiring additional stock. Although the Acquisition Restrictions are designed as
a protective measure to preserve and protect the Company&rsquo;s NOLs, the Acquisition Restrictions may have the effect of impeding
or discouraging a merger, tender offer or proxy contest, even if such a transaction may be favorable to the interests of some or
all of the Company&rsquo;s stockholders. This might prevent stockholders from realizing an opportunity to sell all or a portion
of their shares of common stock at higher than market prices. In addition, the Acquisition Restrictions may delay the assumption
of control by a holder of a large block of capital stock and the removal of incumbent directors and management, even if such removal
may be beneficial to some or all of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Acquisition Restrictions does not purport to be complete and is qualified in its entirety by reference to the Company&rsquo;s
Certificate of Incorporation, which is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Preferred Share Purchase Rights</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&nbsp;12,
2008, Clarus entered into a Rights Agreement (the &ldquo;Rights Agreement&rdquo;) with American Stock Transfer&nbsp;&amp; Trust
Company that provides for the terms of a rights plan including a dividend distribution of one preferred share purchase right (a
 &ldquo;Right&rdquo;) for each outstanding share of common stock. The dividend is payable to Clarus&rsquo; stockholders of record
as of the close of business on February&nbsp;12, 2008 (the &ldquo;Record Date&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board adopted the
Rights Agreement to protect the Company&rsquo;s ability to carry forward its NOLs, which the Company believes are a substantial
asset. The Rights Agreement is designed to assist in limiting the number of 5% or more owners and thus reduce the risk of a possible
 &ldquo;change of ownership&rdquo; under Section&nbsp;382 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;).
Any such &ldquo;change of ownership&rdquo; under these rules&nbsp;would limit or eliminate the ability of the Company to use its
existing NOLs for federal income tax purposes. However, there is no guarantee that the objective of preserving the value of the
NOLs will be achieved. There is a possibility that certain stock transactions may be completed by stockholders or prospective stockholders
that could trigger a &ldquo;change of ownership,&rdquo; and there are other limitations on the use of NOLs set forth in the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights Agreement
imposes a significant penalty upon any person or group that acquires 4.9% or more (but less than 50%) of Clarus&rsquo; then-outstanding
common stock without the prior approval of the Board. Stockholders who own 4.9% or more of Clarus&rsquo; then-outstanding common
stock as of the close of business on the Record Date, will not trigger the Rights Agreement so long as they do not increase their
ownership of common stock. Moreover, the Board may exempt any person or group that owns 4.9% or more. A person or group that acquires
a percentage of common stock in excess of the applicable threshold but less than 50% of Clarus&rsquo; then-outstanding common stock
is called an &ldquo;Acquiring Person.&rdquo; Any Rights held by an Acquiring Person are void and may not be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board authorized
the issuance of one Right per each share of common stock outstanding on the Record Date. If the Rights become exercisable, each
Right would allow its holder to purchase from Clarus one one-hundredth of a share of Clarus&rsquo; Series&nbsp;A Junior Participating
Preferred Stock, par value $0.0001 (the &ldquo;Series&nbsp;A Preferred Stock&rdquo;), for a purchase price of $12.00. Each fractional
share of Series&nbsp;A Preferred Stock would give the stockholder approximately the same dividend, voting and liquidation rights
as one share of common stock. Prior to exercise, however, a Right will not give its holder any dividend, voting or liquidation
rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights will not
be exercisable until 10 days after a public announcement by Clarus that a person or group has become an Acquiring Person. Until
the date that the Rights become exercisable (the &ldquo;Distribution Date&rdquo;), Clarus&rsquo; common stock certificates will
evidence the Rights and will contain a notation to that effect. Any transfer of shares of common stock prior to the Distribution
Date will constitute a transfer of the associated Rights. After the Distribution Date, the Rights will be separated from the common
stock and be evidenced by a rights certificate, which Clarus will mail to all holders of the rights that are not void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a person or group
becomes an Acquiring Person after the Distribution Date or already is an Acquiring Person and acquires more shares after the Distribution
Date, all holders of Rights, except the Acquiring Person, may exercise their rights to purchase shares of Clarus&rsquo; common
stock with a market value of two times the purchase price (or other securities or assets as determined by the Board) upon payment
of the purchase price (a &ldquo;Flip-In Event&rdquo;). After the Distribution Date, if a Flip-In Event has already occurred and
Clarus is acquired in a merger or similar transaction, all holders of the Rights except the Acquiring Person may exercise their
Rights upon payment of the purchase price to purchase shares of the acquiring corporation with a market value of two times the
purchase price of the Rights (a &ldquo;Flip-Over Event&rdquo;). Rights may be exercised to purchase shares of Clarus&rsquo; Series&nbsp;A
Preferred Stock only after the occurrence of the Distribution Date and prior to the occurrence of a Flip-In Event as described
above. A Distribution Date resulting from any occurrence described above would necessarily follow the occurrence of a Flip-In Event,
in which case the Rights could be exercised to purchase shares of common stock or other securities as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights will expire
at such time the Board determines that the NOLs are fully utilized or no longer available under Section&nbsp;382 of the Code or
the Rights are earlier redeemed or exchanged by the Company as described below. The Board may redeem all (but not less than all)
of the Rights for a redemption price of $0.0001 per Right at any time prior to the later of the Distribution Date and the date
of the first public announcement or disclosure by Clarus that a person or group has become an Acquiring Person. Once the Rights
are redeemed, the right to exercise the Rights will terminate, and the only right of the holders of the Rights will be to receive
the redemption price. The redemption price will be adjusted if Clarus declares a stock split or issues a stock dividend on its
common stock. After the later of the Distribution Date and the date of the first public announcement by Clarus that a person or
group has become an Acquiring Person, but before an Acquiring Person owns 50% or more of Clarus&rsquo; outstanding common stock,
the Board may exchange each Right (other than the Rights that have become void) for one share of common stock or an equivalent
security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may adjust
the purchase price of the Series&nbsp;A Preferred Stock, the number of shares of the Series&nbsp;A Preferred Stock issuable and
the number of outstanding Rights to prevent dilution that may occur as a result of certain events, including a stock dividend,
a stock split or a reclassification of the Series&nbsp;A Preferred Stock or common stock. No adjustments to the purchase price
of less than 1% will be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before the time the
Rights cease to be redeemable, the Board may amend or supplement the Rights Agreement without the consent of the holders of the
Rights, except that no amendment may decrease the redemption price below $0.0001 per right. At any time thereafter, the Board may
amend or supplement the Rights Agreement only to cure an ambiguity, to alter time period provisions, to correct inconsistent provisions
or to make any additional changes to the Rights Agreement, but only to the extent that those changes do not impair or adversely
affect any Rights holder and do not result in the Rights becoming redeemable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Rights does not purport to be complete and is qualified in its entirety by reference to the Rights Agreement, which is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="anti"></A><FONT STYLE="text-transform: uppercase"><B>Anti-Takeover
Effects of Certain Provisions of Delaware Law and Our Certificate of Incorporation and Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain provisions
of the Certificate of Incorporation and Bylaws could have an anti-takeover effect. These provisions are intended to enhance the
likelihood of continuity and stability in the composition of the Board and in the policies formulated by the Board and to discourage
an unsolicited takeover of us if the Board determines that such takeover is not in the best interests of us and our stockholders.
However, these provisions could have the effect of discouraging certain attempts to acquire us or remove incumbent management even
if some or a majority of stockholders deemed such an attempt to be in their best interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions in the
Certificate of Incorporation and the Bylaws include: (a)&nbsp;a procedure which requires stockholders to nominate directors in
advance of a meeting to elect such directors; (b)&nbsp;the authority to issue additional shares of preferred stock without stockholder
approval; (c)&nbsp;the number of directors on our Board will be fixed exclusively by the Board; (d)&nbsp;any newly created directorship
or any vacancy in our Board resulting from any increase in the authorized number of directors or the death, disability, resignation,
retirement, disqualification, removal from office or other cause will be filled solely by the affirmative vote of a majority of
the directors then in office, even if less than a quorum; and (e)&nbsp;our Bylaws may be amended by our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Delaware General
Corporation Law (the &ldquo;DGCL&rdquo;) contains statutory &ldquo;anti-takeover&rdquo; provisions, including Section&nbsp;203
of the DGCL which applies automatically to a Delaware corporation unless that corporation elects to opt-out as provided in Section&nbsp;203.
We, as a Delaware corporation, have not elected to opt-out of Section&nbsp;203 of the DGCL. Under Section&nbsp;203 of the DGCL,
a stockholder acquiring more than 15% of the outstanding voting shares of a corporation (an &ldquo;Interested Stockholder&rdquo;)
but less than 85% of such shares may not engage in certain business combinations with the corporation for a period of three years
subsequent to the date on which the stockholder became an Interested Stockholder unless prior to such date, the board of directors
of the corporation approves either the business combination or the transaction which resulted in the stockholder becoming an Interested
Stockholder, or the business combination is approved by the board of directors and by the affirmative vote of at least 66<SUP>2/3</SUP>%
of the outstanding voting stock that is not owned by the Interested Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Limitation of Liability and Indemnification of Officers and
Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to provisions
of the DGCL, we have adopted provisions in our Certificate of Incorporation that provide that our directors shall not be personally
liable for monetary damages to us or our stockholders for a breach of fiduciary duty as a director to the full extent that the
DGCL permits the limitation or elimination of the liability of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have in effect
a directors and officers liability insurance policy indemnifying our directors and officers and the directors and officers of our
subsidiaries within a specific limit for certain liabilities incurred by them, including liabilities under the Securities Act.
We pay the entire premium of this policy. Our Certificate of Incorporation also contains a provision for the indemnification by
us of all of our directors and officers, to the fullest extent permitted by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exclusive Forum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Bylaws provide
that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall,
to the fullest extent permitted by law, be the sole and exclusive forum for (a)&nbsp;any derivative action or proceeding brought
on behalf of the Company, (b)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director, officer, other
employee or stockholder of the Company to the Company or the Company&rsquo;s stockholders, (c)&nbsp;any action asserting a claim
arising pursuant to any provision of the DGCL or as to which the DGCL confers jurisdiction on the Court of Chancery of the State
of Delaware, or (d)&nbsp;any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing
or otherwise acquiring any interest in shares of our stock shall be deemed to have notice of and consented to the foregoing forum
selection provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="planof"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is
a part of an &ldquo;acquisition shelf&rdquo; registration statement on Form&nbsp;S-4 that we have filed with the SEC. Under the
shelf registration process, we may from time to time offer and sell up to 7,500,000 shares of our common stock, par value $$0.0001
per share, in connection with the acquisition of assets, stock or businesses, whether by purchase, merger or any other form of
business combination. We are actively looking for high-quality, durable, cash flow-producing assets potentially unrelated to the
outdoor industry in order to diversify the Company&rsquo;s business and potentially monetize the Company&rsquo;s substantial net
operating losses as part of its asset redeployment and diversification strategy. We intend to focus our search primarily in the
United States, although we will also evaluate international investment opportunities should we find such opportunities attractive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is expected that
the terms of these acquisitions will be determined by direct negotiations with the owners or controlling persons of the assets,
businesses or securities to be acquired, and that the shares of common stock issued will be valued at prices reasonably related
to the market price of our common stock at the time an agreement is entered into concerning the terms of the acquisition, at or
about the time the shares are delivered or during some other negotiated period. Factors taken into account in acquisitions may
include, among other factors, the quality and reputation of the business to be acquired and its management, the strategic market
position of the business to be acquired and its proprietary assets, earning power, cash flow and growth potential. In addition
to shares of our common stock, consideration for these acquisitions may consist of any consideration permitted by applicable law,
including, without limitation, the payment of cash, the issuance of preferred stock, the issuance of a note or other form of indebtedness,
the assumption of liabilities or any combination of these items. All expenses of this registration, other than the expenses of
the selling stockholders, if any, will be paid by us. We do not expect to pay underwriting discounts or commissions, although we
may pay finders&rsquo; fees from time to time in connection with certain acquisitions. Any person receiving finders&rsquo; fees
may be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act, and any profit on the resale of securities
purchased by them may be considered underwriting commissions or discounts under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may
issue our common stock pursuant to this prospectus and applicable prospectus supplement, or post-effective amendment, to acquire
the assets, stock or business of debtors in cases under the United States Bankruptcy Code, which may constitute all or a portion
of the debtor&rsquo;s assets, stock or business. The common stock we issue in these transactions may be sold by the debtor or its
stockholders for cash from time to time in market transactions or it may be transferred by the debtor in satisfaction of claims
by creditors under a plan of reorganization approved by the applicable United States Bankruptcy Court or otherwise transferred
in accordance with the Bankruptcy Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In an effort to maintain
an orderly market in our securities or for other reasons, we may negotiate agreements with persons receiving common stock covered
by this prospectus that will limit the number of shares that they may sell at specified intervals. These agreements may be more
or less restrictive than restrictions on sales made under exemptions from the registration requirements of the Securities Act,
including the requirements under Rule&nbsp;144 or Rule&nbsp;145(d), and the persons party to these agreements may not otherwise
be subject to the Securities Act requirements. We anticipate that, in general, negotiated agreements will be of limited duration
and will permit the recipients of securities issued in connection with acquisitions to sell up to a specified number of shares
during a specified period of time. We may also determine to waive any such agreements without public notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus may
be supplemented to furnish the information necessary for a particular negotiated transaction, and the registration statement of
which this prospectus is a part will be amended or supplemented, as required, to supply information concerning an acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may permit individuals
or entities who will receive shares of our common stock in connection with the acquisitions described above, or their transferees
or successors-in-interest, to use this prospectus to cover the resale of such shares. See &ldquo;Selling Stockholders,&rdquo; as
it may be amended or supplemented from time to time, for a list of those individuals or entities that are authorized to use this
prospectus to sell their shares of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="selling"></A><B>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also prepared
this prospectus, as we may amend or supplement it if appropriate, for use by the persons, and their pledgees, donees, transferees
or other successors in interest, who receive shares of our common stock in acquisitions covered by this prospectus. We refer to
these persons as selling stockholders. Pursuant to the terms of any agreement we may enter into in connection with an acquisition
by the Company of assets, businesses, or securities; under certain circumstances selling stockholders may not be permitted to use
this prospectus to reoffer any shares without first obtaining our prior written consent. We may condition our consent on the agreement
by the selling stockholders that they not offer or sell more than a specified number of shares and that they only do so following
the filing of any required supplements or amendments to this prospectus or such other conditions which we may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholder
will act independently of us in making decisions with respect to the timing, manner and size of each sale. Selling stockholders
may resell shares on the NASDAQ (or any other exchange on which our common stock may be listed or traded from time to time), in
negotiated transactions, in block trades, through the writing of options on securities, or any combination of these methods of
sale, at fixed prices that may be changed, at market prices prevailing at the time of sale, at prices relating to the prevailing
prices or at negotiated prices. These selling stockholders may sell their shares of common stock to or through broker-dealers,
and the broker-dealers may receive compensation in the form of discounts, concessions or commissions from the selling stockholders
or the purchasers of shares for whom the broker-dealer may act as agent or to whom they may sell as principal or both. We will
not receive any proceeds from sales by selling stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders
and any underwriter or broker-dealer retained by the selling stockholder may be deemed to be underwriters within the meaning the
Securities Act. Any profits that the selling stockholders realize and the compensation they pay to any broker-dealer may be deemed
to be underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
resales are to be made through a broker or dealer, a member firm of FINRA may be engaged to act as the selling stockholders' agent
in the sale of shares by such selling stockholders. We anticipate that the commission paid to the member firm will be the normal
commission (including negotiated commissions to the extent permissible). Sales of shares by the member firm may be made </FONT>on
the NASDAQ (or any other exchange on which our common stock may be listed or traded from time to time), in negotiated transactions,
in block trades, through the writing of options on securities, or any combination of these methods of sale, at fixed prices that
may be changed, at market prices prevailing at the time of sale, at prices relating to the prevailing prices or at negotiated prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In an effort to maintain
an orderly market in our securities or for other reasons, we may negotiate agreements with persons receiving common stock covered
by this prospectus that will limit the number of shares that they may sell at specified intervals. These agreements may be more
or less restrictive than restrictions on sales made under exemptions from the registration requirements of the Securities Act,
including the requirements under Rule&nbsp;144 or Rule&nbsp;145(d), and the persons party to these agreements may not otherwise
be subject to the Securities Act requirements. We anticipate that, in general, negotiated agreements will be of limited duration
and will permit the recipients of securities issued in connection with acquisitions to sell up to a specified number of shares
during a specified period of time. We may also determine to waive any such agreements without public notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A post-effective amendment,
if required, will be filed under Rule&nbsp;424(b)&nbsp;under the Securities Act, disclosing the name of any selling stockholders,
the participating securities firm, if any, the number and kind of securities involved and other details of such resale to the extent
appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to comply
with the securities laws of certain states, if applicable, shares covered by this prospectus may be sold in such jurisdictions
only through registered or licensed brokers or dealers. In addition, in certain states, the shares covered by this prospectus may
not be sold unless the shares have been registered or qualified for sale in the applicable state or an exemption from the registration
or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="where"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the
informational requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and in accordance
therewith we are required to file periodic reports, proxy statements and other information with the Commission. Such reports, proxy
statements and other information filed by us can be inspected and copied at the Commission&rsquo;s Public Reference Room located
at 100 F Street, N.E. Washington, D.C. 20549, at the prescribed rates. The Commission also maintains a site on the World Wide Web
that contains reports, proxy and information statements and other information regarding registrants that file electronically. The
address of such site is http://www.sec.gov. Please call 1-800-SEC-0330 for further information on the operation of the Commission&rsquo;s
Public Reference Room.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
traded on NASDAQ under the symbol &ldquo;CLAR.&rdquo; Certain materials filed by us may be inspected at the NASDAQ Stock Market,
One Liberty Plaza, 165 Broadway, New York, NY 10006.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus omits
certain information that is contained in the registration statement on file with the Commission, of which this prospectus is a
part. For further information with respect to us and our securities, reference is made to the registration statement, including
the exhibits incorporated therein by reference or filed therewith. Statements herein contained concerning the provisions of any
document are not necessarily complete and, in each instance, reference is made to the copy of such document filed as an exhibit
or incorporated by reference to the registration statement. Each such statement is qualified in its entirety by such reference.
The registration statement and the exhibits may be inspected without charge at the offices of the Commission or copies thereof
obtained at prescribed rates from the public reference section of the Commission at the addresses set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="incorp"></A>INCORPORATION OF CERTAIN DOCUMENTS BY
REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Commission allows
us to &ldquo;incorporate by reference&rdquo; the information we file with it, which means that we can disclose important business,
financial and other information to you in this prospectus by referring you to the publicly filed documents containing this information.
The information incorporated by reference is deemed to be a part of this prospectus, except for any information superseded by information
contained in this prospectus or filed later by us with the Commission. This prospectus incorporates by reference the documents
set forth below that we have previously filed with the Commission, other than any portion of any such filing that is furnished
under the applicable Commission rules, which documents contain important information about us and our common stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our annual report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016, filed with the Commission
on March&nbsp;6, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our definitive proxy statement filed with the Commission on April&nbsp;28, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our quarterly report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2017, filed with the
Commission on May&nbsp;8, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our quarterly report on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2017, filed with the
Commission on August&nbsp;7, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our quarterly report on Form&nbsp;10-Q for the quarter ended September&nbsp;30, 2017, filed with
the Commission on November&nbsp;7, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our current report on Form&nbsp;8-K filed with the Commission on August&nbsp;14, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our current report on Form&nbsp;8-K filed with the Commission on August&nbsp;25, 2017 and as amended
on Form&nbsp;8-K/A filed with the Commission on October&nbsp;20, 2017;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our current report on Form&nbsp;8-K filed with the Commission on September&nbsp;22, 2017; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the description of our common stock contained in our registration statement on Form&nbsp;8-A/A
filed on June&nbsp;9, 2010, including any amendments or reports filed for the purpose of updating that description; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our registration statement on Form&nbsp;S-3 registering up to $200,000,000 of securities of the
Company, filed with the Commission on June&nbsp;15, 2017 and as amended filed with the Commission on November&nbsp;17, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of such documents
are on file with the Commission. In addition, all documents filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d)&nbsp;of
the Exchange Act, subsequent to the date of this prospectus are incorporated by reference in this prospectus, other than any portion
of any such filing that is furnished under the applicable commission rules, and are a part hereof from the date of filing of such
documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed
to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any subsequently
filed document that is also incorporated by reference herein modifies or replaces such statement. Any statements so modified or
superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any information incorporated
by reference herein is available to you without charge upon written or oral request. If you would like a copy of any of this information,
please submit your request to us at Clarus Corporation, 2084 East 3900 South, Salt Lake City, Utah 84124, Attention: Secretary,
or call (801) 278-5552.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="experts"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Clarus Corporation as of December&nbsp;31, 2016 and 2015 and for each of the years in the three-year period ended
December&nbsp;31, 2016, and management&rsquo;s assessment of the effectiveness of internal control over financial reporting as
of December&nbsp;31, 2016 have been incorporated by reference herein, in reliance on the reports of KPMG LLP, independent registered
public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Sierra Bullets, L.L.C. as of December&nbsp;31, 2016 and 2015, and the related consolidated statements of income,
changes in members&rsquo; equity and cash flows for the years then ended, have been incorporated by reference herein, in reliance
on the reports of Singer Lewak, LLP independent registered public accounting firm, incorporated by reference herein, and upon the
authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="legal"></A><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the
securities offered hereby will be passed upon for us by Kane Kessler, P.C., New York, New York. Any underwriters will be advised
of the other issues relating to any offering by their own legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2012513d1_424b3img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2012513d1_424b3img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !+ )(# 2(  A$! Q$!_\0
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MT:[B[_Q/H_\ SE/QP_X?\_LK_P#1/OC3_P"$?%_\LZ/^'_/[*_\ T3[XT_\
MA'Q?_+.OV/\ ^%,?"G_HG7@7_P )/P[_ /*^C_A3'PI_Z)UX%_\ "3\._P#R
MOH^IY_\ ]#C!?^$/_P!]A_K/X#?]&NXN_P#$^C_\Y3\</^'_ #^RO_T3[XT_
M^$?%_P#+.C_A_P _LK_]$^^-/_A'Q?\ RSK]C_\ A3'PI_Z)UX%_\)/P[_\
M*^C_ (4Q\*?^B=>!?_"3\.__ "OH^IY__P!#C!?^$/\ ]]A_K/X#?]&NXN_\
M3Z/_ ,Y3\</^'_/[*_\ T3[XT_\ A'Q?_+.C_A_S^RO_ -$^^-/_ (1\7_RS
MK]D/^%+?"O\ Z)QX&_\ "2\/?_*^C_A2WPK_ .B<>!O_  DO#W_ROH^IY_\
M]#C!?^$/_P!]D_ZT^ __ $:_BW_Q/8__ #F/QN_X?\?LK!B?^%?_ !GYQU\&
M#.<=<_VDIR?H*]=_9Z_X+&_L[?M(_&WP-\"?!WAOXA:5XM\>2ZRFCOXF\/?V
M?8(-%\.:WXCN!/<_VB<'^S]#OCTY8#/8K^ELGP>^%NU@/AUX"&2=K'PAH1X
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MCS/B1X=OQI_C#0? 7@_QA\1%\&76<SV7B/5/!^B:MIFGZQ:8 O="^UG6;/\
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M@W[.?[2?A#QQXX>VNKRS\&:C9^)? ?BS4;:Q/GWL^D^&_B#HGA76M8@M+?\
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MBVM[B"YN]*UW2[*\%I<6M]]D^Q7EJ6_S8_\ @D/^QKX _P""KO[5G[5'AO\
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MW-2?<;_?K^=?]IS_ )3Y_L4?]D<U/_U'_P!HJOZ)Y#F/ZO\ EU-?SM?M,_\
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M@_\ A%:I_P#':/\ A_1^PC_T&_B#_P"$5JG_ ,=K]'_^&9?V>O\ HB_PW_\
M"3TC_P"1J/\ AF7]GK_HB_PW_P#"3TC_ .1J/9\1_P#07DW_ (18W_YL#^T_
MH\?]$'XD?^)GDW_SF/S@_P"']'["/_0;^(/_ (16J?\ QVC_ (?T?L(_]!OX
M@_\ A%:I_P#':_1__AF7]GK_ *(O\-__  D](_\ D:C_ (9E_9Z_Z(O\-_\
MPD](_P#D:CV?$?\ T%Y-_P"$6-_^; _M/Z/'_1!^)'_B9Y-_\YC\X/\ A_1^
MPC_T&_B#_P"$5JG_ ,=H_P"']'["/_0;^(/_ (16J?\ QVOT?_X9E_9Z_P"B
M+_#?_P )/2/_ )&H_P"&9?V>O^B+_#?_ ,)/2/\ Y&H]GQ'_ -!>3?\ A%C?
M_FP/[3^CQ_T0?B1_XF>3?_.8_.#_ (?T?L(_]!OX@_\ A%:I_P#':/\ A_1^
MPC_T&_B#_P"$5JG_ ,=K]'_^&9?V>O\ HB_PW_\ "3TC_P"1J/\ AF7]GK_H
MB_PW_P#"3TC_ .1J/9\1_P#07DW_ (18W_YL#^T_H\?]$'XD?^)GDW_SF/S@
M_P"']'["/_0;^(/_ (16J?\ QVC_ (?T?L(_]!OX@_\ A%:I_P#':_1__AF7
M]GK_ *(O\-__  D](_\ D:C_ (9E_9Z_Z(O\-_\ PD](_P#D:CV?$?\ T%Y-
M_P"$6-_^; _M/Z/'_1!^)'_B9Y-_\YC\X/\ A_1^PC_T&_B#_P"$5JG_ ,=H
M_P"']'["/_0;^(/_ (16J?\ QVOT?_X9E_9Z_P"B+_#?_P )/2/_ )&H_P"&
M9?V>O^B+_#?_ ,)/2/\ Y&H]GQ'_ -!>3?\ A%C?_FP/[3^CQ_T0?B1_XF>3
M?_.8_-U_^"\/[!3@H=<^(>P'( \":D!]>+@9]<<_3BOSJT_]K/X1_MC_ /!:
M_P#8^^)7PBFU:^\+:)\/_$WA"X;6M*GT>\.IZ?X*^-NJS&&QN ,0_8-;LC]I
MZ= 2<G/](,'[,/[.WE.?^%*?#3.&.?\ A$=&]#_TZ^PK3\.? KX,^$M9L-?\
M,?"[P-H&MV!N19:OI/AO2['4;0.HTY_L]Y;VZ3Q;K&XGM#L<9@FDCZ.<\;PF
M=8VK@Z.+Q^#C2PV.P6*2PV$<'S85\R2YGHY6WZ;:([\NXZ\&>&:/$%;A/@?C
MS#YQF7#.<<.87&9SQEE^-P6$_MK O!XK%/!83*,)*;Y4VH+$?>>WQ./+CX/W
/$_\ 01[T4VBOKS^;S__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
